333 related articles for article (PubMed ID: 34518918)
1. Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.
Arcani R; Colle J; Cauchois R; Koubi M; Jarrot PA; Jean R; Boyer A; Lachamp J; Tichadou A; Couderc AL; Farnault L; Costello R; Venton G; Kaplanski G
Ann Hematol; 2021 Nov; 100(11):2799-2803. PubMed ID: 34518918
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 in patients with hematological malignancies: A retrospective case series.
Infante MS; González-Gascón Y Marín I; Muñoz-Novas C; Churruca J; Foncillas MÁ; Landete E; Marín K; Ryan P; Hernández-Rivas JÁ
Int J Lab Hematol; 2020 Dec; 42(6):e256-e259. PubMed ID: 32749757
[No Abstract] [Full Text] [Related]
3. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
4. Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit - High mortality rate in infected patients with haematologic malignancies.
Biernat MM; Zińczuk A; Biernat P; Bogucka-Fedorczuk A; Kwiatkowski J; Kalicińska E; Marciniak D; Simon K; Wróbel T
J Clin Virol; 2020 Sep; 130():104574. PubMed ID: 32769026
[TBL] [Abstract][Full Text] [Related]
5. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
Sanchez-Pina JM; Rodríguez Rodriguez M; Castro Quismondo N; Gil Manso R; Colmenares R; Gil Alos D; Paciello ML; Zafra D; Garcia-Sanchez C; Villegas C; Cuellar C; Carreño-Tarragona G; Zamanillo I; Poza M; Iñiguez R; Gutierrez X; Alonso R; Rodríguez A; Folgueira MD; Delgado R; Ferrari JM; Lizasoain M; Aguado JM; Ayala R; Martinez-Lopez J; Calbacho M
Eur J Haematol; 2020 Nov; 105(5):597-607. PubMed ID: 32710500
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India.
Gupta A; Desai N; Sanjeev ; Chauhan P; Nityanand S; Hashim Z; Gupta M
Ann Hematol; 2022 Jan; 101(1):69-79. PubMed ID: 34559278
[TBL] [Abstract][Full Text] [Related]
7. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.
Wang Q; Berger NA; Xu R
Blood Rev; 2021 May; 47():100775. PubMed ID: 33187811
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India.
Jain A; Nayak L; Kulkarni UP; Mehra N; Yanamandra U; Kayal S; Damodar S; John JM; Mehta P; Singh S; Munot P; Selvarajan S; Radhakrishnan V; Lad D; Kapoor R; Dubashi B; Bharath RS; Jain H; Jayachandran PK; Lakshmanan J; Mani T; Thorat J; Das S; Karunamurthy O; George B; Sengar M; Malhotra P
Blood Cancer J; 2022 Jan; 12(1):2. PubMed ID: 34987161
[No Abstract] [Full Text] [Related]
11. Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients - a prospective observational study.
Auvinen R; Nohynek H; Syrjänen R; Ollgren J; Kerttula T; Mäntylä J; Ikonen N; Loginov R; Haveri A; Kurkela S; Skogberg K
Infect Dis (Lond); 2021 Feb; 53(2):111-121. PubMed ID: 33170050
[TBL] [Abstract][Full Text] [Related]
12. Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Russell B; Moss CL; Shah V; Ko TK; Palmer K; Sylva R; George G; Monroy-Iglesias MJ; Patten P; Ceesay MM; Benjamin R; Potter V; Pagliuca A; Papa S; Irshad S; Ross P; Spicer J; Kordasti S; Crawley D; Wylie H; Cahill F; Haire A; Zaki K; Sita-Lumsden A; Josephs D; Enting D; Swampillai A; Sawyer E; D'Souza A; Gomberg S; Harrison C; Fields P; Wrench D; Rigg A; Sullivan R; Kulasekararaj A; ; Dolly S; Van Hemelrijck M
Br J Cancer; 2021 Sep; 125(7):939-947. PubMed ID: 34400804
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection.
Brendish NJ; Poole S; Naidu VV; Mansbridge CT; Norton N; Borca F; Phan HT; Wheeler H; Harvey M; Presland L; Clark TW
J Infect; 2020 Dec; 81(6):937-943. PubMed ID: 32998038
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results.
Broseta JJ; Rodríguez-Espinosa D; Cuadrado E; Guillén-Olmos E; Hermida E; Montagud-Marrahi E; Rodas L; Vera M; Fontseré N; Arias M; Cases A; Maduell F
Blood Purif; 2021; 50(4-5):531-538. PubMed ID: 33352569
[TBL] [Abstract][Full Text] [Related]
15. Invasive pulmonary aspergillosis: comparative analysis in cancer patients with underlying haematologic malignancies versus solid tumours.
Dib RW; Khalil M; Fares J; Hachem RY; Jiang Y; Dandachi D; Chaftari AM; Raad II
J Hosp Infect; 2020 Mar; 104(3):358-364. PubMed ID: 31585141
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
17. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study.
Oliva A; Curtolo A; Volpicelli L; Cancelli F; Borrazzo C; Cogliati Dezza F; Marcelli G; Gavaruzzi F; Di Bari S; Ricci P; Turriziani O; Mastroianni CM; Venditti M
Infection; 2022 Oct; 50(5):1373-1382. PubMed ID: 35781785
[TBL] [Abstract][Full Text] [Related]
19. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.
Borah P; Mirgh S; Sharma SK; Bansal S; Dixit A; Dolai TK; Lunkad S; Gupta N; Singh G; Jain A; Bansal D; Choudhary D; Khandelwal V; Doval D; Kumar M; Bhargava R; Chakrabarti A; Kalashetty M; Rauthan A; Kazi B; Mandal PK; Jeyaraman P; Naithani R;
Blood Cells Mol Dis; 2021 Mar; 87():102525. PubMed ID: 33338697
[TBL] [Abstract][Full Text] [Related]
20. Cycle threshold predicted mortality in a cohort of patients with hematologic malignancies infected with SARS-CoV-2.
Santarelli IM; Manzella DJ; Gallo Vaulet ML; Rodríguez Fermepín M; Crespo Y; Toledo Monaca S; Dobarro M; Fernández SI
Rev Argent Microbiol; 2023; 55(3):246-250. PubMed ID: 37208258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]